Class information for:
Level 1: IAVI NEUTRALIZING ANTIBODY//DUKE HUMAN VACCINE//HIV AIDS VACCINE IMMUNOL IMMUNOGEN DISCOVER

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
758 3100 58.0 93%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
7 4 INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY 1353914
29 3       HIV//VIROLOGY//HIV 1 108954
10 2             AIDS RESEARCH AND HUMAN RETROVIRUSES//VIROLOGY//HIV 1 39664
758 1                   IAVI NEUTRALIZING ANTIBODY//DUKE HUMAN VACCINE//HIV AIDS VACCINE IMMUNOL IMMUNOGEN DISCOVER 3100

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 IAVI NEUTRALIZING ANTIBODY address 881224 3% 89% 101
2 DUKE HUMAN VACCINE address 750645 5% 47% 161
3 HIV AIDS VACCINE IMMUNOL IMMUNOGEN DISCOVER address 592600 2% 81% 74
4 INT AIDS VACCINE INITIAT NEUTRALIZING ANTIBODY CT address 451361 2% 83% 55
5 BROADLY NEUTRALIZING ANTIBODIES authKW 450643 2% 74% 62
6 VACCINE address 391978 10% 13% 313
7 NEUTRALIZING ANTIBODIES authKW 341058 7% 16% 214
8 IMMUNOL MICROBIAL SCI address 295400 6% 17% 175
9 VIROL VACCINE address 172828 2% 33% 53
10 VIROLOGY WoSSC 167920 56% 1% 1725

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Virology 167920 56% 1% 1725
2 Immunology 16758 36% 0% 1108
3 Infectious Diseases 9838 17% 0% 535
4 Medicine, Research & Experimental 1117 8% 0% 253
5 Microbiology 673 8% 0% 234
6 Parasitiology 591 3% 0% 92
7 Biochemistry & Molecular Biology 402 14% 0% 433
8 Biochemical Research Methods 139 3% 0% 100
9 Cell Biology 117 5% 0% 165
10 Biophysics 76 3% 0% 92

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 IAVI NEUTRALIZING ANTIBODY 881224 3% 89% 101
2 DUKE HUMAN VACCINE 750645 5% 47% 161
3 HIV AIDS VACCINE IMMUNOL IMMUNOGEN DISCOVER 592600 2% 81% 74
4 INT AIDS VACCINE INITIAT NEUTRALIZING ANTIBODY CT 451361 2% 83% 55
5 VACCINE 391978 10% 13% 313
6 IMMUNOL MICROBIAL SCI 295400 6% 17% 175
7 VIROL VACCINE 172828 2% 33% 53
8 SCRIPPS HIV AIDS VACCINE IMMUNOL IMMUNOGEN 159538 1% 90% 18
9 NEUTRALIZING ANTIBODY 138724 1% 78% 18
10 RAGON 134267 2% 20% 67

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 JOURNAL OF VIROLOGY 121170 22% 2% 697
2 AIDS RESEARCH AND HUMAN RETROVIRUSES 53100 5% 3% 170
3 RETROVIROLOGY 34123 2% 5% 65
4 CURRENT OPINION IN HIV AND AIDS 29570 2% 6% 50
5 CURRENT HIV RESEARCH 19140 1% 5% 40
6 VIROLOGY 13729 5% 1% 162
7 PLOS PATHOGENS 11087 3% 1% 79
8 AIDS 8336 3% 1% 86
9 VACCINE 6925 4% 1% 114
10 JOURNAL OF INFECTIOUS DISEASES 2551 2% 0% 69

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 BROADLY NEUTRALIZING ANTIBODIES 450643 2% 74% 62 Search BROADLY+NEUTRALIZING+ANTIBODIES Search BROADLY+NEUTRALIZING+ANTIBODIES
2 NEUTRALIZING ANTIBODIES 341058 7% 16% 214 Search NEUTRALIZING+ANTIBODIES Search NEUTRALIZING+ANTIBODIES
3 HIV 1 155242 12% 4% 363 Search HIV+1 Search HIV+1
4 GP41 144002 2% 22% 68 Search GP41 Search GP41
5 HIV 1 VACCINE 142960 1% 44% 33 Search HIV+1+VACCINE Search HIV+1+VACCINE
6 MPER 135826 1% 69% 20 Search MPER Search MPER
7 ENVELOPE GLYCOPROTEIN 125616 2% 23% 55 Search ENVELOPE+GLYCOPROTEIN Search ENVELOPE+GLYCOPROTEIN
8 GP120 103521 3% 12% 87 Search GP120 Search GP120
9 4E10 99302 0% 92% 11 Search 4E10 Search 4E10
10 HIV VACCINE 94571 2% 17% 57 Search HIV+VACCINE Search HIV+VACCINE

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 SANDERS, RW , MOORE, JP , (2017) NATIVE-LIKE ENV TRIMERS AS A PLATFORM FOR HIV-1 VACCINE DESIGN.IMMUNOLOGICAL REVIEWS. VOL. 275. ISSUE 1. P. 161 -182 170 85% 2
2 BURTON, DR , HANGARTNER, L , (2016) BROADLY NEUTRALIZING ANTIBODIES TO HIV AND THEIR ROLE IN VACCINE DESIGN.ANNUAL REVIEW OF IMMUNOLOGY, VOL 34. VOL. 34. ISSUE . P. 635 -659 148 96% 15
3 LEWIS, GK , PAZGIER, M , DEVICO, AL , (2017) SURVIVORS REMORSE: ANTIBODY-MEDIATED PROTECTION AGAINST HIV-1.IMMUNOLOGICAL REVIEWS. VOL. 275. ISSUE 1. P. 271 -284 144 75% 2
4 STAMATATOS, L , PANCERA, M , MCGUIRE, AT , (2017) GERMLINE-TARGETING IMMUNOGENS.IMMUNOLOGICAL REVIEWS. VOL. 275. ISSUE 1. P. 203 -216 125 96% 1
5 BURTON, DR , MASCOLA, JR , (2015) ANTIBODY RESPONSES TO ENVELOPE GLYCOPROTEINS IN HIV-1 INFECTION.NATURE IMMUNOLOGY. VOL. 16. ISSUE 6. P. 571 -576 99 96% 79
6 WEST, AP , SCHARF, L , SCHEID, JF , KLEIN, F , BJORKMAN, PJ , NUSSENZWEIG, MC , (2014) STRUCTURAL INSIGHTS ON THE ROLE OF ANTIBODIES IN HIV-1 VACCINE AND THERAPY.CELL. VOL. 156. ISSUE 4. P. 633-648 120 81% 101
7 SLIEPEN, K , SANDERS, RW , (2016) HIV-1 ENVELOPE GLYCOPROTEIN IMMUNOGENS TO INDUCE BROADLY NEUTRALIZING ANTIBODIES.EXPERT REVIEW OF VACCINES. VOL. 15. ISSUE 3. P. 349 -365 143 85% 4
8 MASCOLA, JR , HAYNES, BF , (2013) HIV-1 NEUTRALIZING ANTIBODIES: UNDERSTANDING NATURE'S PATHWAYS.IMMUNOLOGICAL REVIEWS. VOL. 254. ISSUE . P. 225-244 136 76% 121
9 MCCOY, LE , BURTON, DR , (2017) IDENTIFICATION AND SPECIFICITY OF BROADLY NEUTRALIZING ANTIBODIES AGAINST HIV.IMMUNOLOGICAL REVIEWS. VOL. 275. ISSUE 1. P. 11 -20 95 97% 1
10 DE TAEYE, SW , MOORE, JP , SANDERS, RW , (2016) HIV-1 ENVELOPE TRIMER DESIGN AND IMMUNIZATION STRATEGIES TO INDUCE BROADLY NEUTRALIZING ANTIBODIES.TRENDS IN IMMUNOLOGY. VOL. 37. ISSUE 3. P. 221 -232 103 99% 6

Classes with closest relation at Level 1


Rank Class id link
1 12424 HIV VACCINE//MOL MUCOSAL VACCINE IMMUNOL GRP//HIV VACCINE TRIALS NETWORK
2 10596 ENFUVIRTIDE//GP41//FUSION INHIBITOR
3 1121 AIDS RESEARCH AND HUMAN RETROVIRUSES//V3 LOOP//GP120
4 34386 MOL BIOL VIRAL ONCOGENESIS//HYPERVARIABLE EPITOPE CONSTRUCTS//LENTIVIRAL VLP
5 3332 SIV//SHIV//SIMIAN IMMUNODEFICIENCY VIRUS
6 21318 ANTI R7V ANTIBODIES//C ADE//UNITE IMMUNORETROVIROL HUMAINE
7 772 CCR5//CCR5 ANTAGONIST//MARAVIROC
8 22345 CYANOVIRIN N//GRIFFITHSIN//SCYTOVIRIN
9 20980 EXPOSED UNINFECTED//HESN//HIV EXPOSED SERONEGATIVE
10 1456 PARTNERS AIDS//DORIS DUKE MED//HIV PATHOGENESIS PROGRAMME

Go to start page